Medigen Vaccine Biologics Corporation (6547.TWO)
TWD 43.55
(-9.93%)
TWD 43.55
(-9.93%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 383.63 Million TWD | -29.58% |
| 2022 | 544.78 Million TWD | -3.32% |
| 2021 | 563.49 Million TWD | 627.73% |
| 2020 | 77.43 Million TWD | 822.36% |
| 2019 | 8.39 Million TWD | -17.45% |
| 2018 | 10.17 Million TWD | 44.67% |
| 2017 | 7.03 Million TWD | 144.86% |
| 2016 | 2.87 Million TWD | 114.13% |
| 2015 | -20.32 Million TWD | 95.06% |
| 2014 | -411.2 Million TWD | 0.0% |
| 2013 | - TWD | 0.0% |
| 2012 | - TWD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 473.36 Million TWD | 16.14% |
| 2024 Q1 | 407.56 Million TWD | 6.24% |
| 2023 Q1 | 539.61 Million TWD | -0.95% |
| 2023 Q3 | 840.77 Million TWD | -4.67% |
| 2023 Q2 | 881.96 Million TWD | 63.44% |
| 2023 Q4 | 383.63 Million TWD | -54.37% |
| 2023 FY | 383.63 Million TWD | -29.58% |
| 2022 Q4 | 544.78 Million TWD | -27.23% |
| 2022 Q3 | 748.58 Million TWD | -0.23% |
| 2022 Q2 | 750.33 Million TWD | 26.53% |
| 2022 FY | 544.78 Million TWD | -3.32% |
| 2022 Q1 | 593 Million TWD | 5.24% |
| 2021 Q2 | 750.52 Million TWD | 712.56% |
| 2021 FY | 563.49 Million TWD | 627.73% |
| 2021 Q4 | 563.49 Million TWD | -30.06% |
| 2021 Q1 | 92.36 Million TWD | 19.29% |
| 2021 Q3 | 805.62 Million TWD | 7.34% |
| 2020 Q4 | 77.43 Million TWD | 91.49% |
| 2020 FY | 77.43 Million TWD | 822.36% |
| 2020 Q1 | 12.35 Million TWD | 47.12% |
| 2020 Q2 | 12.27 Million TWD | -0.6% |
| 2020 Q3 | 40.43 Million TWD | 229.36% |
| 2019 FY | 8.39 Million TWD | -17.45% |
| 2019 Q2 | 12.56 Million TWD | -6.84% |
| 2019 Q3 | 10.57 Million TWD | -15.87% |
| 2019 Q4 | 8.39 Million TWD | -20.58% |
| 2019 Q1 | 13.48 Million TWD | 32.63% |
| 2018 Q4 | 10.17 Million TWD | 24.05% |
| 2018 FY | 10.17 Million TWD | 44.67% |
| 2018 Q3 | 8.19 Million TWD | 4.75% |
| 2018 Q2 | 7.82 Million TWD | -15.69% |
| 2018 Q1 | 9.28 Million TWD | 32.03% |
| 2017 Q3 | 4.21 Million TWD | 18.44% |
| 2017 Q2 | 3.56 Million TWD | 0.0% |
| 2017 Q1 | - TWD | 0.0% |
| 2017 FY | 7.03 Million TWD | 144.86% |
| 2017 Q4 | 7.03 Million TWD | 66.63% |
| 2016 Q1 | - TWD | 100.0% |
| 2016 Q2 | - TWD | 0.0% |
| 2016 Q4 | - TWD | 0.0% |
| 2016 FY | 2.87 Million TWD | 114.13% |
| 2015 Q3 | -20.32 Million TWD | 0.0% |
| 2015 Q1 | - TWD | 100.0% |
| 2015 Q2 | - TWD | 0.0% |
| 2015 FY | -20.32 Million TWD | 95.06% |
| 2015 Q4 | -20.32 Million TWD | 0.0% |
| 2014 FY | -411.2 Million TWD | 0.0% |
| 2014 Q1 | - TWD | 0.0% |
| 2014 Q3 | -411.2 Million TWD | 0.0% |
| 2014 Q4 | -411.2 Million TWD | 0.0% |
| 2013 FY | - TWD | 0.0% |
| 2012 FY | - TWD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 505 Thousand TWD | -75867.327% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 459.97 Million TWD | 16.597% |
| Level Biotechnology Inc. | 88.85 Million TWD | -331.778% |
| Sagittarius Life Science Corp | 31.54 Million TWD | -1116.306% |
| NeoCore Technology Co., Ltd. | 66.38 Million TWD | -477.929% |
| TaiMed Biologics Inc. | 1.26 Billion TWD | 69.678% |
| GlycoNex Incorporation | 17.4 Million TWD | -2104.419% |
| VBI | 10.03 Million TWD | -3722.97% |
| GeneReach Biotechnology Corp. | 67.37 Million TWD | -469.411% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.17 Million TWD | -1712.078% |
| SynCore Biotechnology Co.,Ltd | 3.12 Million TWD | -12184.182% |
| Genomics BioSci & Tech. Co.,Ltd. | 61.5 Million TWD | -523.705% |
| Visgeneer Inc. | 49.07 Million TWD | -681.764% |
| Mycenax Biotech Inc. | 112.32 Million TWD | -241.537% |
| Sunmax Biotechnology Co., Ltd. | 93.67 Million TWD | -309.56% |
| G&E Herbal Biotechnology Co., Ltd. | 22.9 Million TWD | -1574.969% |
| Neith Corporation | 463 Thousand TWD | -82758.531% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -4.78 Million TWD | 8110.754% |
| Enimmune corporation | 15.7 Million TWD | -2343.379% |
| TaiRx, Inc. | 11 Thousand TWD | -3487490.909% |
| CHO Pharma, Inc. | 1.00 TWD | -38363499900.0% |
| EirGenix Inc. | 680.63 Million TWD | 43.636% |
| BioLASCO Taiwan Co., Ltd. | 32.52 Million TWD | -1079.544% |
| Sunny Pharmtech Inc. | 97.03 Million TWD | -295.341% |
| Lin BioScience, Inc. | - TWD | -Infinity% |
| BioGend Therapeutics Co., Ltd. | 16.54 Million TWD | -2218.737% |
| Feng Chi Biotech Corp. | 19.03 Million TWD | -1915.207% |
| Bio Preventive Medicine Corp. | 1.23 Million TWD | -30888.288% |
| Lukas Biomedical Inc. | 36.72 Million TWD | -944.615% |
| RBC Bioscience Corporation | 44.42 Million TWD | -763.595% |
| BiOptic Inc. | 161.07 Million TWD | -138.176% |
| BRIM Biotechnology, Inc. | -6.23 Million TWD | 6249.968% |
| Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
| Great Novel Therapeutics Biotech & Medicals | 6.16 Million TWD | -6126.83% |
| Syngen Biotech Co.,Ltd. | 348.98 Million TWD | -9.928% |
| Advagene Biopharma Co., Ltd. | -91.99 Thousand TWD | 417099.098% |
| NaviFUS Corp. | 6.87 Million TWD | -5481.769% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 12.16 Million TWD | -3052.819% |
| Sinew Pharma Inc. | -766 Thousand TWD | 50182.898% |
| Andros Pharmaceuticals Co.,Ltd | 1.08 Million TWD | -35160.57% |
| Greenyn Biotechnology Co., Ltd | 163.13 Million TWD | -135.163% |
| Lumosa Therapeutics Co., Ltd. | 103.91 Million TWD | -269.192% |
| AP Biosciences Inc | - TWD | -Infinity% |
| Medigen Biotechnology Corp. | 546.9 Million TWD | 29.854% |
| 3D Global Biotech Inc. | 3.59 Million TWD | -10571.349% |
| Pharmosa Biopharm Inc. | 21.9 Million TWD | -1651.038% |
| Intech Biopharm Corporation | 41.52 Million TWD | -823.865% |
| Oneness Biotech Co., Ltd. | 122.73 Million TWD | -212.567% |
| Eusol Biotech Co.,Ltd. | -8.1 Million TWD | 4835.065% |
| TWi Biotechnology, Inc. | -435 Thousand TWD | 88291.954% |
| Ever Supreme Bio Technology Co., Ltd | 69.08 Million TWD | -455.301% |
| TCI GENE Inc. | 54.84 Million TWD | -599.464% |
| MegaPro Biomedical Co., Ltd | 20.51 Million TWD | -1770.478% |
| Senhwa Biosciences, Inc. | - TWD | -Infinity% |
| Taiwan Bio Therapeutics Co., Ltd | 40.96 Million TWD | -836.517% |
| NatureWise Biotech & Medicals Corporation | 82.5 Million TWD | -365.012% |
| PharmaEngine, Inc. | 15.9 Million TWD | -2312.647% |
| Savior Lifetec Corporation | 860.04 Million TWD | 55.394% |
| TaiGen Biopharmaceuticals Holdings Limited | 34.15 Million TWD | -1023.251% |
| OBI Pharma, Inc. | 25.93 Million TWD | -1379.388% |
| Meribank Biotech Co., Ltd | 6.9 Million TWD | -5454.293% |
| Acepodia, Inc. | 39.52 Million TWD | -870.54% |
| Caliway Biopharmaceuticals Co., Ltd. | 1.02 Million TWD | -37400.978% |